US4795433A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Automatic injector for emergency treatment
Assignee: ING (US) Corp
•
Filing: 1988-03-31
•
Granted: 1989-01-03
•
Expires: 2008-03-31
Abstract
Abstract A method of treating a patient with liquid medicament under circumstances where intravenous injection is not practical but the fast response time of an intravenous injection is desirable, including the treatment of individuals undergoing heart attack symptoms with t-PA. The method comprises the steps of injecting the liquid medicament t-PA preferably with a blood absorption enhancing agent such as hydroxylamine hydrochloride into the muscle tissue of the patient, applying to the patient which has received the injection repeated blood flow stimulating cycles, each of which includes a period of electrical stimulus during which the muscle tissue which has received the injection tenses followed by a period of no electrical stimulus during which the muscle tissue which received the injection is allowed to relax inducing enhanced blood flow within the muscle tissue, and continuing the application of the repeated blood flow stimulating cycles until the injected liquid medicament has been sufficiently absorbed into the enhanced blood flow to achieve a desired possible patient response of reperfusion and apparatus for carrying out the method.
Inventors
- 👤 Stanley J. Sarnoff
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:06
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/415; A61K47/00; A61K47/06; A61K47/16; A61K47/18; A61M; A61M5/00; A61M5/178; A61M5/20; A61M5/2066; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/327; A61M5/19; A61N1/36; A61N1/36014; A61N1/3603
Claims Analysis
Total Claims: 42
Claim 1
Independent Claim
189 words
Apparatus for treating a patient with a liquid medicament for purposes of establishing reperfusion under circumstances where intravenous injection is not practical but the fast response time of an intravenous injection is desirable comprising an automatic injector assembly including outer housing means, medicament cartridge means mounted within said outer housing means in a storage position, said medicament cartridge means including a hypodermic needle, a plurality of medicament containers, and a plurality of medicament ingredients in said medicament containers, moving means within said outer housing means for effecting movement of said medicament cartridge means out of said storage position, mixing means within said outer housing means operable when said medicament cartridge means is moved out of said storage position for mixing the medicament ingredients to form a liquid medicament, said moving means including stressed spring means releasable for effecting movement of said hypodermic needle outwardly of said outer housing means into the muscle tissue of the patient and said mixed liquid medicament outwardly through said needle into the muscle tissue of the patient, said mixed liquid medicament including a clot selective coronary thrombolytic agent and a blood absorption enhancing agent.
Claim 2
Dependent Claim
189 words
Apparatus for treating a patient with a liquid medicament for purposes of establishing reperfusion under circumstances where intravenous injection is not practical but the fast response time of an intravenous injection is desirable comprising an automatic injector assembly including outer housing means, medicament cartridge means mounted within said outer housing means in a storage position, said medicament cartridge means including a hypodermic needle, a plurality of medicament containers, and a plurality of medicament ingredients in said medicament containers, moving means within said outer housing means for effecting movement of said medicament cartridge means out of said storage position, mixing means within said outer housing means operable when said medicament cartridge means is moved out of said storage position for mixing the medicament ingredients to form a liquid medicament, said moving means including stressed spring means releasable for effecting movement of said hypodermic needle outwardly of said outer housing means into the muscle tissue of the patient and said mixed liquid medicament outwardly through said needle into the muscle tissue of the patient, said mixed liquid medicament including a clot selective coronary thrombolytic agent and a blood absorption enhancing agent.
Claim 3
Dependent Claim
13 words
Apparatus as defined in claim 1 wherein said coronary thrombolytic agent is t-PA.
Claim 4
Dependent Claim
14 words
Apparatus as defined in claim 2 wherein said liquid medicament includes an anti-arrythmic agent.
Claim 5
Dependent Claim
12 words
Apparatus as defined in claim 3 wherein said anti-arrythmic agent is lidocaine.
Claim 6
Dependent Claim
14 words
Apparatus as defined in claim 4 wherein said liquid medicament includes an anti-reclotting agent.
Claim 7
Dependent Claim
15 words
Apparatus as defined in claim 5 wherein said anti-reclotting agent is a thromboxane synthetase inhibitor.
Claim 8
Dependent Claim
13 words
Apparatus as defined in claim 6 wherein said thromboxane synthetase inhibitor is dazoxiben.
Claim 9
Dependent Claim
19 words
Apparatus as defined in claim 3 wherein said anti-reclotting agent is an antagonist for the receptor of thromboxane A.
Claim 10
Dependent Claim
18 words
Apparatus as defined in claim 8 wherein said antagonist for the receptor of thromboxane A is SQ 27,427.
Claim 11
Dependent Claim
16 words
Apparatus as defined in claim 5 wherein said liquid medicament includes a reperfusion damage preventing agent.
Claim 12
Dependent Claim
15 words
Apparatus as defined in claim 10 wherein said reperfusion damage preventing agent is superoxide dismutase.
Claim 13
Dependent Claim
15 words
Apparatus as defined in claim 10 wherein said reperfusion damage preventing agent is S-aminotrimethyleneaminoethyl thiophosphate.
Claim 14
Dependent Claim
14 words
Apparatus as defined in claim 1 wherein said liquid medicament includes an anti-reclotting agent.
Claim 15
Dependent Claim
15 words
Apparatus as defined in claim 13 wherein said anti-reclotting agent is a thromboxane synthetase inhibitor.
Claim 16
Dependent Claim
12 words
Apparatus as defined in claim 14 wherein said thromboxane synthetase is dazoxiben.
Claim 17
Dependent Claim
19 words
Apparatus as defined in claim 13 wherein said anti-reclotting agent is an antagonist for the receptor of thromboxane A.
Claim 18
Dependent Claim
18 words
Apparatus as defined in claim 16 wherein said antagonist for the receptor of thromboxane A is SQ 27,427.
Claim 19
Independent Claim
197 words
A device for initiating treatment of a coronary prone individual at a time during the early minutes or hours after the onset of heart attack symptoms, said device comprising automatic injector means comprising outer housing means, medicament cartridge assembly means mounted within said housing means in a storage position for movement out of said storage position, cartridge moving means mounted in said housing means for moving said medicament cartridge assembly means out of said storage position, said medicament cartridge assembly means including container means, hypodermic needle means, and medicament means disposed in a storage condition within said container means when said medicament cartridge assembly means is in said storage position operable when said medicament cartridge assembly means is moved out of said storage position to provide liquid medicament injectable through said hypodermic needle means, said moving means including stressed spring assembly means for moving said hypodermic needle means outwardly of said housing means into the muscle tissue of a patient and said liquid medicament outwardly through said hypodermic needle means into the muscle tissue of a patient, said liquid medicament including an agent for preventing platelet aggregation in the blood when absorbed therein from the muscle tissue.
Claim 20
Independent Claim
197 words
A device for initiating treatment of a coronary prone individual at a time during the early minutes or hours after the onset of heart attack symptoms, said device comprising automatic injector means comprising outer housing means, medicament cartridge assembly means mounted within said housing means in a storage position for movement out of said storage position, cartridge moving means mounted in said housing means for moving said medicament cartridge assembly means out of said storage position, said medicament cartridge assembly means including container means, hypodermic needle means, and medicament means disposed in a storage condition within said container means when said medicament cartridge assembly means is in said storage position operable when said medicament cartridge assembly means is moved out of said storage position to provide liquid medicament injectable through said hypodermic needle means, said moving means including stressed spring assembly means for moving said hypodermic needle means outwardly of said housing means into the muscle tissue of a patient and said liquid medicament outwardly through said hypodermic needle means into the muscle tissue of a patient, said liquid medicament including an agent for preventing platelet aggregation in the blood when absorbed therein from the muscle tissue.
Claim 21
Dependent Claim
17 words
A device as defined in claim 18 wherein said liquid medicament includes a blood absorption enhancing agent.
Claim 22
Dependent Claim
18 words
A device as defined in claim 19 wherein said liquid medicament includes a clot selective coronary thrombolytic agent.
Claim 23
Dependent Claim
14 words
A device as defined in claim 20 wherein said coronary thrombolytic agent is t-PA.
Claim 24
Dependent Claim
16 words
A device as defined in claim 21 wherein said liquid medicament also includes an anti-arrythmic agent.
Claim 25
Dependent Claim
13 words
A device as defined in claim 22 wherein said anti-arrythmic agent is lidocaine.
Claim 26
Dependent Claim
18 words
A device as defined in claim 18 wherein said platelet aggregation preventing agent is a thromboxane synthetase inhibitor.
Claim 27
Dependent Claim
14 words
A device as defined in claim 24 wherein said thromboxane synthetase inhibitor is dazoxiben.
Claim 28
Dependent Claim
22 words
A device as defined in claim 18 wherein said platelet aggregation preventing agent is an antagonist for the receptor of thromboxane A.
Claim 29
Dependent Claim
19 words
A device as defined in claim 26 wherein said antagonist for the receptor of thromboxane A is SQ 27,427.
Claim 30
Dependent Claim
19 words
A device as defined in claim 18 wherein said platelet aggregation preventing agent is aspirin, indomethacin, naproxea, or sulfinpyrazone.
Claim 31
Dependent Claim
15 words
A device as defined in claim 18 wherein said platelet aggregation preventing agent is aspirin.
Claim 32
Dependent Claim
16 words
A device as defined in claim 18 wherein said liquid medicament also includes an anti-arrythmic agent.
Claim 33
Dependent Claim
13 words
A device as defined in claim 30 wherein said anti-arrythmic agent is lidocaine.
Claim 34
Dependent Claim
16 words
A device as defined in claim 24 wherein said liquid medicament also includes an anti-arrythmic agent.
Claim 35
Dependent Claim
13 words
A device as defined in claim 32 wherein said anti-arrythmic agent is lidocaine.
Claim 36
Dependent Claim
16 words
A device as defined in claim 26 wherein said liquid medicament also includes an anti-arrythmic agent.
Claim 37
Dependent Claim
13 words
A device as defined in claim 34 wherein said anti-arrythmic agent is lidocaine.
Claim 38
Dependent Claim
16 words
A device as defined in claim 28 wherein said liquid medicament also includes an anti-arrythmic agent.
Claim 39
Dependent Claim
13 words
A device as defined in claim 36 wherein said anti-arrythmic agent is lidocaine.
Claim 40
Dependent Claim
194 words
Apparatus for treating a patient with a liquid medicament for purposes of establishing reperfusion under circumstances where intravenous injection is not practical but the fast response time of an intravenous injection is desirable comprising an automatic injector assembly including outer housing means, medicament cartridge means mounted within said outer housing means in a storage position, said medicament cartridge means including a hypodermic needle, a plurality of medicament ingredient containers, a powder medicament ingredient in one of said containers and a diluent ingredient in another of said containers, moving means within said outer housing means for effecting movement of said medicament cartridge means out of said storage position, mixing means within said outer housing means operable when said medicament cartridge means is moved out of said storage position for mixing the powder and diluent ingredients to form a liquid medicament, said moving means including stressed spring means releasable for effecting movement of said hypodermic needle outwardly of said outer housing means into the muscle tissue of the patient and said mixed liquid medicament outwardly through said needle into the muscle tissue of the patient, said mixed liquid medicament including a clot selective coronary thrombolytic agent.
Claim 41
Dependent Claim
194 words
Apparatus for treating a patient with a liquid medicament for purposes of establishing reperfusion under circumstances where intravenous injection is not practical but the fast response time of an intravenous injection is desirable comprising an automatic injector assembly including outer housing means, medicament cartridge means mounted within said outer housing means in a storage position, said medicament cartridge means including a hypodermic needle, a plurality of medicament ingredient containers, a powder medicament ingredient in one of said containers and a diluent ingredient in another of said containers, moving means within said outer housing means for effecting movement of said medicament cartridge means out of said storage position, mixing means within said outer housing means operable when said medicament cartridge means is moved out of said storage position for mixing the powder and diluent ingredients to form a liquid medicament, said moving means including stressed spring means releasable for effecting movement of said hypodermic needle outwardly of said outer housing means into the muscle tissue of the patient and said mixed liquid medicament outwardly through said needle into the muscle tissue of the patient, said mixed liquid medicament including a clot selective coronary thrombolytic agent.
Claim 42
Dependent Claim
13 words
Apparatus as defined in claim 38 wherein said coronary thrombolytic agent is t-PA.
References Cited (Backward Citations)
US2771554A
Cited
US3078850A
Cited
US3380449A
Cited
US3364929A
Cited
US3565080A
Cited
US3391695A
Cited
US3424155A
Cited
US3807411A
Cited
US3882863A
Cited
US4031893A
Cited
US4103690A
Cited
US4226235A
Cited
US4394863A
Cited
US4658830A
Cited
US4661469A
Cited
US4656034A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-01-03 | 1992-07-04 | 1993-01-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-01-03 | 1996-07-04 | 1997-01-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-01-03 | 2000-07-04 | 2001-01-03 | $7700.00 | Window Closed / Lapsed |